SCHEMBL13315784

SCHEMBL13315784

Cc1ccc(-c2cn(-c3cc4ccccc4oc3=O)nn2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.47
▸ HPGD P15428 3/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ GLA P06280 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ ALDH1A1 P00352 7/20 0.47
▸ MAPT P10636 3/20 0.47
▸ SRC P12931 1/20 0.46
▸ CYP2A6 P11509 1/20 0.44
▸ APP P05067 3/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ NPC1 O15118 4/20 0.43
▸ RAB9A P51151 4/20 0.43
▸ POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3550958 0.90 SRC (0.52) KDM4EHPGDSMN1; SMN2ALDH1A1MAPT
SCHEMBL13315789 0.85 MIF (0.56) KDM4EHPGDGLAMEN1KMT2A
SCHEMBL13315786 0.85 P2RY14 (0.47) SRCAPPPTGS2CA12CA9
SCHEMBL13315783 0.83 MEN1 (0.49) MEN1KMT2ASRCAPPNPC1
SCHEMBL13315785 0.79 RAB9A (0.44) KDM4EHPGDGLAMEN1KMT2A
SCHEMBL13315808 0.79 TNKS (0.44) SMN1; SMN2ALDH1A1SRCNPSR1PTGS2
SCHEMBL13315807 0.78 ADORA3 (0.61) SMN1; SMN2ALDH1A1MAPTNPSR1RXFP1
SCHEMBL13315790 0.78 MIF (0.54) HPGDALDH1A1SRCNPC1TDP1
SCHEMBL2248079 0.78 BCHE (0.44) MAPTSRCAPPNPC1PTGS2
SCHEMBL13315799 0.76 MAPT (0.58) KDM4EHPGDCYP1A2GLAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745229-B2 Chemoselective fluorgenic molecular linkers and methods for their preparation and use UNIVERSITY OF SOUTH CAROLINA 2010-06-29 — — US disclosed
US-7745229-B2 Chemoselective fluorgenic molecular linkers and methods for their preparation and use UNIVERSITY OF SOUTH CAROLINA 2010-06-29 — — US disclosed
US-20070224695-A1 Chemoselective Fluorgenic Molecular Linkers and Methods for Their Preparation and Use UNIVERSITY OF SOUTH CAROLINA (US) 2007-09-27 — — US disclosed
US-20070224695-A1 Chemoselective Fluorgenic Molecular Linkers and Methods for Their Preparation and Use UNIVERSITY OF SOUTH CAROLINA (US) 2007-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070224695-A1 Chemoselective Fluorgenic Molecular Linkers and Methods for Their Preparation and Use KIT, HLCS, ALK KDM4E 1692/4885HPGD 4259/4885CYP1A2 4438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback